Sanofi Asserts 2nd Uroxatral Patent Against Sun
The suit, filed Wednesday in the U.S. District Court for the District of Delaware, accuses Sun of infringing U.S. Patent Number 4,661,491, one of two patents that Sanofi has asserted in litigation over the drug Uroxatral.
Sanofi filed suit in September in the same court against Sun and several other generics manufacturers for allegedly infringing U.S....
Already a subscriber? Click here to login